Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-01-26
DOI
10.3389/fmicb.2023.1088187
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Risk assessment with gut microbiome and metabolite markers in NAFLD development
- (2022) Howell Leung et al. Science Translational Medicine
- Chicken jejunal microbiota improves growth performance by mitigating intestinal inflammation
- (2022) Xiaolong Zhang et al. Microbiome
- Effects of Dietary Nutrients on Fatty Liver Disease Associated With Metabolic Dysfunction (MAFLD): Based on the Intestinal-Hepatic Axis
- (2022) Nan Yao et al. Frontiers in Nutrition
- Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism
- (2022) Yuanyuan Lei et al. Nature Communications
- How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
- (2021) Yana Geng et al. Hepatology International
- Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways
- (2021) Sayed H Seif el-Din et al. HUMAN & EXPERIMENTAL TOXICOLOGY
- The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus
- (2021) Chae Bin Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Non-alcoholic fatty liver disease
- (2021) Elizabeth E Powell et al. LANCET
- Short-Chain Fatty Acids, Maternal Microbiota and Metabolism in Pregnancy
- (2021) Maciej Ziętek et al. Nutrients
- Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV
- (2021) Matthew J. Budoff et al. Diabetes Therapy
- High-Fiber, Whole-Food Dietary Intervention Alters the Human Gut Microbiome but Not Fecal Short-Chain Fatty Acids
- (2021) Andrew Oliver et al. mSystems
- Gut Microbiota and Type 2 Diabetes Mellitus: Association, Mechanism, and Translational Applications
- (2021) Lili Zhang et al. MEDIATORS OF INFLAMMATION
- Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
- (2021) Daniel Ferguson et al. Nature Reviews Endocrinology
- Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota
- (2021) Wen-Long Sun et al. Cell Reports
- Treatment of type 2 diabetes: challenges, hopes, and anticipated successes
- (2021) Michael A Nauck et al. Lancet Diabetes & Endocrinology
- Editorial: The Brain – Gut – Microbiome Network in Metabolic Regulation and Dysregulation
- (2021) Pierre De Meyts et al. Frontiers in Endocrinology
- In vivo commensal control of Clostridioides difficile virulence
- (2021) Brintha P. Girinathan et al. Cell Host & Microbe
- Dissolving microneedle-assisted long-acting Liraglutide delivery to control type 2 diabetes and obesity
- (2021) Morteza Rabiei et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation
- (2020) Sidhartha R. Sinha et al. Cell Host & Microbe
- Metformin Disrupts Bile Acid Efflux by Repressing Bile Salt Export Pump Expression
- (2020) Brandy Garzel et al. PHARMACEUTICAL RESEARCH
- Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet
- (2020) Ningjing Zhang et al. Biomed Research International
- Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)
- (2020) Benjamin A. Lipsky et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Gypenosides regulate farnesoid X receptor-mediated bile acid and lipid metabolism in a mouse model of non-alcoholic steatohepatitis
- (2020) Hongshan Li et al. Nutrition & Metabolism
- SCFA: mechanisms and functional importance in the gut
- (2020) Camille Martin-Gallausiaux et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Nonalcoholic Fatty Liver Disease Is Associated With Low Skeletal Muscle Mass in Overweight/Obese Youths
- (2020) Lucia Pacifico et al. Frontiers in Pediatrics
- The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non‐Alcoholic Fatty Liver Disease
- (2020) Yinhua Ni et al. MOLECULAR NUTRITION & FOOD RESEARCH
- The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
- (2020) Daniela Maria Tanase et al. Journal of Diabetes Research
- Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)
- (2020) Mohammad S. Kuchay et al. DIABETOLOGIA
- Gut Microbiota in Hypertension and Atherosclerosis: A Review
- (2020) Barbara J. H. Verhaar et al. Nutrients
- Rapid microbial community evolution in initial Carex litter decomposition stages in Bayinbuluk alpine wetland during the freeze–thaw period
- (2020) Mo Chen et al. ECOLOGICAL INDICATORS
- Gut microbial metabolites in obesity, NAFLD and T2DM
- (2019) Emanuel E. Canfora et al. Nature Reviews Endocrinology
- Emerging roles of bile acids in mucosal immunity and inflammation
- (2019) Mei Lan Chen et al. Mucosal Immunology
- Liraglutide in Children and Adolescents with Type 2 Diabetes
- (2019) William V. Tamborlane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer
- (2019) Shinichi Yachida et al. NATURE MEDICINE
- Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier
- (2018) Eric C. Martens et al. NATURE REVIEWS MICROBIOLOGY
- Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial
- (2018) Xiaolin Tong et al. mBio
- Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
- (2018) Emma T. Saltzman et al. Frontiers in Microbiology
- Evaluation of the effects of dapagliflozin, an SGLT2 inhibitor, on hepatic steatosis and fibrosis by transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease
- (2018) Masanori Shimizu et al. DIABETES OBESITY & METABOLISM
- Liraglutide modulates gut microbiota and reduces NAFLD in obese mice
- (2018) GV Moreira et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
- (2018) Feng Tian et al. BIOSCIENCE REPORTS
- Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models
- (2018) Ashfaq Ahmad et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
- (2018) Lulu Sun et al. NATURE MEDICINE
- Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug
- (2017) Hao Wu et al. NATURE MEDICINE
- Randomized trial comparing the effects of gliclazide, liraglutide, and metformin on diabetes with non-alcoholic fatty liver disease
- (2017) Wenhuan Feng et al. Journal of Diabetes
- Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients
- (2016) Mark M. Smits et al. DIABETES OBESITY & METABOLISM
- Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes
- (2016) Ildiko Lingvay et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The role of the gut microbiota in NAFLD
- (2016) Christopher Leung et al. Nature Reviews Gastroenterology & Hepatology
- Diet Dominates Host Genotype in Shaping the Murine Gut Microbiota
- (2015) Rachel N. Carmody et al. Cell Host & Microbe
- Systematic Analysis of the Association between Gut Flora and Obesity through High-Throughput Sequencing and Bioinformatics Approaches
- (2014) Chih-Min Chiu et al. Biomed Research International
- Molecular mechanism of action of metformin: old or new insights?
- (2013) Graham Rena et al. DIABETOLOGIA
- Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
- (2013) Richard S. Legro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Inhibitory effect of Bifidobacterium infantis-mediated sKDR prokaryotic expression system on angiogenesis and growth of Lewis lung cancer in mice
- (2012) Zhao-Jun Li et al. BMC CANCER
- The importance of the gut microbiota after bariatric surgery
- (2012) Judith Aron-Wisnewsky et al. Nature Reviews Gastroenterology & Hepatology
- Influence of polygenetic polymorphisms on the susceptibility to non-alcoholic fatty liver disease of Chinese people
- (2009) Yong-Jian Zhou et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now